Cellular Imaging: a Key Phenotypic Screening Strategy for Predictive Toxicology

Incorporating phenotypic screening as a key strategy will enhances confidence in the predictivity and translatability of drug discovery efforts. Cellular imaging serves as the a phenotypic anchor to identify important toxicologic pathology that encompasses an array of underlying mechanisms, thus provides an effective means to reduce drug development failures due to insufficient safety. This mini-review highlights the latest advances in hepatotoxicity, cardiotoxicity, and genetic toxicity tests that utilized cellular imaging as a screening strategy, and recommends path forward for further improvement.

Abstract licence: CC BY

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.